AP Robinson, JZ Zhang, HE Titus,
M Karl… - Scientific reports, 2020 - nature.com
Abstract Development of pharmacotherapies that promote remyelination is a high priority for
multiple sclerosis (MS), due to their potential for neuroprotection and restoration of function …